- Home
- Medical Device Software: Complying with the MDR & FDA Regulations
Medical Device Software: Complying with the MDR & FDA Regulations Training Course
An introduction to medical device software regulations and requirements to include the latest EU and FDA guidance and risk management.
Details
Course overview
This intensive three-day course provides a comprehensive appraisal of the regulations and requirements that apply to medical device software worldwide. The programme will be highly interactive, using real-life examples and state-of-the-art practices identified by Notified Bodies in Europe. There will be in-depth coverage on how to prepare compliant technical file documentation for medical device software products and a review of software specification, risk management, architectures, usability and resulting design documentation. Presentations will also offer practical tips on how to streamline the development process and provide an understanding of the regulatory requirements and how Notified Bodies review technical files.
There will be sessions on the practical implication of risk management and usability and an analysis of the differences between FDA guidance and MDR guidance on medical device software. Software recalls, the use of apps in medical devices, the implications of the new draft usability standard, and advice on how to validate your system design will also be addressed.
PLEASE NOTE DAY 3 CAN BE BOOKED AS A ONE DAY COURSE, PLEASE CONTACT US IF YOU WOULD LIKE TO TAKE THIS OPTION ON: info@management-forum.co.uk
Why you should attend
- Learn how to qualify and classify software in Europe and the rest of the world
- Get in-depth understanding of the interpretations of MDR Classification Rules 10, 11, 12, 13, 15 and 22
- Understand the implications of the MDR and US Code of Federal Regulations for software
- Gain regulatory guidance on mobile apps, software as a service, cloud computing, artificial intelligence and continuous learning software
- Learn how to write 510(k) and technical files
- Get a practical understanding of quality management, design control and how it applies to agile software development
- Hear the best practices on cyber security, risk management, usability andvalidation
- Learn the principles of clinical evaluations for software as a medical device
- Gain an insight into state-of-the-art standards applicable to software
Who should attend?
- Senior management and project leaders
- Software product managers, researchers, developers and clinical experts
- Software development process managers
- IT managers and integrators
- Internal and external auditors and/or consultants
- Regulatory affairs professionals
- Quality system and quality assurance personnel
- Technical and medical writers
- GUI designers
Programme
Introduction to the regulations
Software qualification – is it a medical device or not?
- Medical device definitions
- In-vitro diagnostic software
- Multi-functionality software
- Cloud computing and software as a service
- Intended purpose
- Excluded functionality
- Borderline with lifestyle and fitness software
- Borderline with pharmaceuticals, combination products
- Companion diagnostics, medication management and adherence apps
- Population health and educational software
- Resource and workflow management vs clinical decision support software
- Clinical decision software
Considerations for placement on the market
- International comparisons-qualification differences (US, Canada, Brazi,…)
- Pitfalls with the interpretation of the IMDRF SaMD risk framework
- Pros and cons of the modular approach
- software platforms
- Software accessories, systems components
Case studies – qualification
Software classification
- Implementing rules
- Software that drives or influences the use of a (hardware) medical
device - Classification rules, including classification rule 11
- IMDRF SaMD risk type determination
Case studies – classification
MDR in a nutshell with software considerations
- Go to market process
- Engaging with a Notified Body
- Controlling software suppliers and subcontractors
- UDI number
- EUDAMED
- Declaration of Conformity
- Person responsible for regulatory compliance
- Software traceability
- Distributors, importers, authorised representatives and their liability
- App stores and digital distribution platforms
- Software recalls
- Unannounced Notified Body audits
- Service updates, upgrades and other changes
Safety and performance requirements for software
- Common specifications
- GSPR checklist
- Software labelling
- Instructions for use
Practical construction of a technical file
- Content
- Example
Placing medical device software on the US market
- US Code of Federal Regulations and its' implications for software
- 510(k) process
- FDA guidance for software
Practical construction of a 510(k)
- Challenges faced for app developers to have their app taken up in care pathways
- Quality and reliability of health and wellness apps
- Evolving policy and reimbursement landscapes for digital health technologies
- Quality and reliability of health and wellness apps
International go-to-market considerations
Controlled design of heath software
- Software development models
- Symptoms and root causes of poor design control
- Waterfall vs Agile, iterative and spiral
- Principles of good design control
- Stage-gated model
- Design activities
- Project management
- Development planning
- Change management
- Requirements management
- Architecture & design
- Development
- Configuration management
- Verification & validation
- Defect management
- Design reviews
- Software development standards
- IEC 62304 software life-cycle management
- IEC 82304-1 general requirements for product safety
- Outsourcing
- Management of software suppliers
- Critical suppliers
- Use of open source software
- Legacy software
Software usability
- Managing the human element of risk
- Designing for happiness
- Terminology, roles and responsibilities
- Use Experience Design (USD)
- Process and techniques
- Formative evaluation
- User observations
- Walkthroughs
- Heuristic review
- Key-stroke level model
- Summative evaluation
- Product reaction cards / word association
- Single Ease Question (SEQ)
- System Usability Score (SUS)
- Interface with risk management
- Regulatory requirements and standards
- EU MDR/IVDR requirements
- USA FDA requirements
- IEC 62366-1, etc.
- Usability guides
Clinical evaluations
- Definitions, purpose, deliverables
- Process and key characteristics
- Methodology
- Selecting data sources
- The literature review process
- Defining a scope and a sufficient level of clinical evidence for medical device software
- Role of validation and usability
- Considerations for artificial intelligence and continuous learning software
Practical construction of a clinical evaluation plan and report
Development of a literature review protocol
Case studies – clinical evaluation of medical device software
Clinical investigations
- General principles of clinical investigations
- When is a clinical investigation needed for medical device software
- Selecting appropriate study design
- Application of standards
- Clinical performance studies
- Generating evidence of effectiveness
- Challenges of health trials
- Reporting
- Regulatory and ethical considerations
Safety risk management – ISO 14971
- Process, terminology, roles
- Risk identification methodologies
- Checklists
- Grey box
- Hazard and Operability Analysis (HAZOP)
- Failure Modes and Effects Anaylsis (FMEA)
- Fault Tree Analysis (FTE)
- Risk Control
- Inherently safe design
- Preventive measures
- Corrective measures
- Mitigations
- Safety notices
- Disclosures of residual risk
- Risk control strategies
- Risk assessment and evaluation
- IMDRF terminology
- Determining severity and probability of harm
- Determining if a risk is acceptable
- Benefit-risk assessment
- Deliverables
- Manufacturer accountability
- Risk management throughout the product life-cycle
- Normal,abnormal and misuse
- ESCs, SOUPs and COTs
- Platform changes and failures
Case studies – risk management
Post-Market Surveillance
- Post-market regulatory requirements
- Components of an effective PMS
- Process interface with CAPA, NC, vigilance, service, periodic safety updates, trend reporting
- Implementation of Post Market Clinical Follow-up for medical device software
- Real-world evidence
- Successfully bringing together risk management, clinical evaluation and PMS to streamline ways of working
Presenters
Koen Cobbaert (More...)
Koen Cobbaert is Quality and Regulatory Manager at Philips Healthcare. He represents COCIR in numerous work groups at European level. COCIR is the European Trade Association representing the medical imaging, radiotherapy, health ICT and electro-medical industries. In 2009 COCIR created its software task force, which Koen has been chairing ever since. He put on paper the first draft of the qualification decision tree, which was later successfully adopted by the Member States in “MEDDEV 2.1/6 on the qualification and classification of standalone software”.
Under Koen’s leadership COCIR’s software task force has contributed to the 1st and 2nd edition of this MEDDEV and has proposed the IMDRF work item on software as a medical device, which ultimately lead to IMDRF guidance on the qualification, risk stratification and clinical evaluation of software as a medical device. Currently Koen’s work focuses on drafting the European guidance for classification of medical device software, which is expected to clarify among others the use of classification rule 10 and 11 under the Medical Device Regulation (MDR).
Koen wrote several COCIR papers on a variety of software-related topics under the MDR: qualification of and responsibilities for rules engines, programming and runtime environments and libraries for dataflow programming and machine learning, economic operator requirements for app stores and digital marketplaces, significant changes of software, UDI numbers, etc.Via COCIR’s standards focus group he contributed to the development of IEC 82304 on safety requirements for health software and IEC 62304 on software lifecycle processes. Koen co-authored the FAQ on IEC 62304, which has been translated in several languages. Via COCIR’s North American sister organisation MITA he also contributed to several FDA guidance papers, including the guidance papers on patient and clinical decision support systems and on computer-assisted detection devices applied to radiology images and radiology device data.
Koen has over 15 years of hands-on experience in establishing regulatory strategies, writing technical files and 510(k)s, performing worldwide regulatory submissions and moderating risk management and clinical evaluation discussions for software applications for general radiology, oncology, neurology, cardiology and orthopaedics, computer algorithms for pattern recognition, computer aided detection, reasoning engines, decision support, clinical pathways, general systems such as HIS, LIS, IVD, PACS, EPR and mobile apps. He has a Master in Risk Management and Electrical Engineering.
Zuzanna Kwade (More...)
Zuzanna Kwade is Medical Affairs Manager, Agfa Healthcare. Zusanna holds a PhD in Biochemistry and has more than ten years of experience in clinical and medical research. She is the co-author of several white papers on regulatory aspects of clinical research.
Since 2016, she has been actively involved in Clinical Evaluations according to MEDDEV 2.7.1 (Rev.4) for multiple devices, including high risk hardware devices and medical software. She also represents COCIR in the European Union Task Force on clinical evaluation of software.
Book now
Book now
|
17-19 Nov 2020 Live webinar |
|||
|
17-19 Nov 2020 Live webinar |
GBP 1,249.00 EUR 1,809.00 USD 2,056.00 Until 6 Oct* |
Enrol now Limited places to attend Live webinar |
|
|
28-30 Apr 2021 Live webinar |
|||
|
28-30 Apr 2021 Live webinar |
GBP 1,249.00 EUR 1,809.00 USD 2,056.00 Until 17 Mar 21* |
Enrol now
to attend Live webinar |
|
|
5-7 May 2021 Face-to-face, (venue not yet confirmed) |
|||
|
5-7 May 2021 Face-to-face (venue not yet confirmed) |
GBP 1,549.00 EUR 2,169.00 USD 2,416.00 Until 24 Mar 21* |
Enrol now
to attend Face-to-face (venue not yet confirmed) |
|
|
27-29 Oct 2021 Live webinar |
|||
|
27-29 Oct 2021 Live webinar |
GBP 1,249.00 EUR 1,809.00 USD 2,056.00 Until 15 Sep 21* |
Enrol now
to attend Live webinar |
|
|
3-5 Nov 2021 Face-to-face, (venue not yet confirmed) |
|||
|
3-5 Nov 2021 Face-to-face (venue not yet confirmed) |
GBP 1,549.00 EUR 2,169.00 USD 2,416.00 Until 22 Sep 21* |
Enrol now
to attend Face-to-face (venue not yet confirmed) |
|
Learn more about our face-to-face and webinar training formats.
* Note the early booking discount cannot be combined with any other offers or promotional code
.jpg)
Customised in-house training
We can customise this course to meet the requirements of your organisation and deliver it at your location and/or online.
You may also be interested in
- EC Medical Devices Vigilance System and Post Marketing Surveillance
- The Pharma Mini MBA
- An Introduction to the Medical Device Regulation
- Drug/Device and Device/Drug Combinations in the EU and USA
- The Medical Device Summer School - From Concept to CE Marking
- Medical Device Software: Complying with the MDR & FDA Regulations
- Medical Device Studies: Clinical Evidence
- New Medical Device Regulation
- Medical Device Studies: Regulatory Requirements and Adverse Event Reporting
- Medical Device Regulation in the Eurasian Union, Russia and the CIS
Previous customers include...
- Bayer Consumer Care AG
- Bespak Europe Ltd
- Boston Scientific
- Bournemouth University
- Bristows LLP
- Covidien Deutschland GmbH
- DCA Design International
- Dentsply Implants
- DePuy Synthes
- Fresenius Medical Care Deutschland GmbH
- GSK
- Hoffman LaRoche
- IBA
- Inpeco SA
- Lyfstone
- McLaren
- MED-EL Medical Electronics
- Medex by Guerbet
- Medicines and Healthcare Products Regulatory Agency (MHRA)
- Medicines and Medical Devices Agency of Serbia
- Novartis Pharma AG
- PA Consulting
- Perspectum Diagnostics
- Quanta Dialysis Technologies
- Radiometer Medical ApS
- Roche
- Saudi Food and Drug Authority
- SGR Consulting Services Ltd
- Technology Partnership Plc
- Vision RT Limited
“Both very good and enthusiastic speakers. It is very nice that they work with MDSW and have a lot of examples, which makes it more understandable. I liked the course and learned a lot. ”
Jennie Mettivier Meijer, Project Manager Medical Devices & Quality Systems, BioTop Medical, Nov 19
“Both speakers were really good and brought the needed perspective to the discussion.”
Sandra Beltran Rodil, Senior Manager Regulatory Affairs, Teva UK Ltd, Apr 19
“Good”
Arun Mahendran, Regulatory Affairs Manager, Vision RT Limited, Apr 19
“A very worthwhile introduction to the regulatory requirements of medical device software for anyone new to this device type. The course covered a broad range of relevant subjects and was delivered by speakers who were clearly highly experienced but also passionate about the subject matter. I would definitely recommend! ”
Suzanne Morgan, Group Head of Regulatory Affairs, The BBI Group, Apr 19
“The course is well thought and based on the expert's experiences. ”
Ana Burman, Quality Engineer, Team Consulting, Apr 19
“Good course, very interesting and complete overview with speakers that bring the insights of both an ex-auditor and an industry representative. ”
Antoine Nguyen, Associate Regulatory Program Manager , Roche , Apr 19
“A good intensive course - I would recommend for my colleagues especially who need a general understanding of MDR impact on medical SW. ”
Camilla Inesa Cernajute, Regulatory Affairs Officer, Oticon A/S, Apr 19
“A very interesting and informative course. Excellent speakers”
Laura Scatizzi, Manager, Fresenius Medical Care Deutschland GmbH, Nov 18
“One of the best training courses I have attended.”
Ben Sadowyj, Senior Regulatory Assciate - Digital, RB Healthcare UK, Nov 18
“This is one of the best training organised by Management Forum in term of the quality of the content and presenters. I am equipped to do my job! ”
Cadence Tan, Senior Regulatory Affairs Manager, GSK Consumer Healthcare, Nov 18
“Engaging delivery of the subject by speakers who clearly had extensive knowledge and experience of medical device software in a regulatory environment.”
Stephen Matthews, Validation Consultant, Smart Process Solutions Ltd., Nov 18
“Big thank you to Koen! He shared the latest information of the risk classification guidance.”
Marika Miettinen, Head of Compliance, Tieto Oyj, Nov 18
“Koen brought a lot of practical industry experience which was extremely useful. ”
Leon Doorn, Sr. QA/RA Manager, Aidence B.V., May 18
“A well structured, well presented programme”
Peter Ogrodnik, Professor of Biomedical Engineering, Keele University, Nov 17
“Good course. A lot of information in detail.”
Jose Fernandez, Certification Manager, McLaren , Nov 17